header logo image


Page 4«..3456..1020..»

Archive for the ‘Cell Therapy’ Category

Animal cells for a younger you

Saturday, February 28th, 2015

THE contemporary age brings a lot of new things that leave people in awe, amazement, and sometimes, in disbelief and disagreement. One thing that the more advanced technology gave birth to is the controversial Stem Cell Therapy (SCT).

According to mayoclinic.org, SCT is the replacement of damaged or diseased stem cells by injecting or infusing healthy stems into your body.

An article from philstar.com also says that SCT replaces or supports ones degenerating tissues and organs. The stem cells used in this technology are capable of developing into different kinds of cells, thus, are also called master cells.

According to bethematch.org, the diseases that are treatable by SCT are leukemia, bone marrow diseases, inherited immune system disorders, and diseases with poorly functioning red blood cells.

SCT is also used as an anti-aging treatment. Some of the prominent Filipinos have used this therapy to maintain their youthful glow and energy.

In the Philippines, clinics offering SCT have sprouted like mushrooms due to its perceived benefits to the patients. In fact, Makati Medical Center has its Cellular Therapeutics Center, equipped with facilities from Germany, USA, and Japan.

In an article from makatimed.net, it was said that the center has an extensive range of services that boast the remarkable efficacy of stem cells.

Dr. Florencio Q. Lucero who started the use of adult SCT in the Philippines in 2006, was quoted in an article from inquirer.net saying that in the Philippines, most of the customers rich businessmen and public officials who are mostly males.

One of them is Manila Mayor Joseph Estrada. He had his SCT at a clinic in Germany called Villa Medica on April 2012. Another article from inquirer.net said that Estrada had 14 shots of blood from the donor animal, the unborn sheep, on his buttocks.

In the same article, Estrada was quoted saying he could sleep better, his knees are working better, and that his skin has shown its glow.

Read this article:
Animal cells for a younger you

Read More...

Stem cell therapy a boon to Parkinson’s patients

Thursday, February 26th, 2015

Bengaluru:Feb 27, 2015, DHNS

Two courses of stem cell therapy have helped Ashok Kumar, 59, who suffered from tremors and rigidity due to Parkinsons disease, recover completely, much to the joy of his family. The man was brought inside my cabin in a wheelchair. He was unable to even sit on the chair without support. Today, he walks independently. Stem cell therapy has made it possible for him, said Dr Naseem Sadiq, Director, Plexus Neuro and Stem Cell Research Centre, who began treating Kumar in October, last year.

Previously, medication and surgical procedure were the only treatment option for Parkinsons disease. Medication in the long-term often lacks effectiveness and may cause side effects, while surgery is not always feasible. Lately, stem cell therapy has turned out to be a boon for patients with Parkinsons, Dr Sadiq said.

Kumar is among the few who have benefited from stem cell therapy. However, though the State has been reporting an increase in the number of registered stem cell donors, it is far behind sufficient as the genetic match between donor and recipient could be anywhere between one in 10,000 and one in two million, according to experts.

Speaking to Deccan Herald, Raghu Rajgopal, co-founder, Datri, a registry for stem cell donation, said, The response we get from Karnataka when we conduct stem cell camps is great. We see a lot of people and registering with us.

As many as 6,000 people have registered from the State under the Datri registry. A total of 72,000 people have registered across the country. In Kerala, 11,000 have signed up, the highest so far, he said.

Among the common myths are that by donating stem cells one turns infertile and weak, have increased chances of cancer and also that there would be excess loss of blood, he said.

According to studies, over one lakh people are diagnosed with Leukemia (blood cancer) and other blood disorders every year in India. The Indian Council of Medical Research has predicted that by the end of 2015, Leukemia cases will reach an estimated 1,17,649 and 1,32,574 by 2020. Stem cell therapy is a widely used treatment mechanism for Leukemia.

Go to Top

View post:
Stem cell therapy a boon to Parkinson's patients

Read More...

Stem cell therapy a boon for Parkinson patients

Thursday, February 26th, 2015

Bengaluru, Feb 25, 2015, dhns:

Two courses of stem cell therapy have helped Ashok Kumar, 59, who suffered from tremors and rigidity due to Parkinsons disease, recover completely, much to the joy of his family.

The man was brought inside my cabin in a wheelchair. He was unable to even sit on the chair without support. Today, he walks independently. Stem cell therapy has made it possible for him, said Dr Naseem Sadiq, Director, Plexus Neuro and Stem Cell Research Centre, who began treating Kumar in October, last year.

Previously, medication and surgical procedure were the only treatment option for Parkinsons disease. Medication in the long-term often lacks effectiveness and may cause side effects, while surgery is not always feasible. Lately, stem cell therapy has turned out to be a boon for patients with Parkinsons, Dr Sadiq said.

Kumar is among the few who have benefited from stem cell therapy. However, though the State has been reporting an increase in the number of registered stem cell donors, it is far behind sufficient as the genetic match between donor and recipient could be anywhere between one in 10,000 and one in two million, according to experts.

Speaking to Deccan Herald, Raghu Rajgopal, co-founder, Datri, a registry for stem cell donation, said, The response we get from Karnataka when we conduct stem cell camps is great. We see a lot of people and registering with us.

As many as 6,000 people have registered from the State under the Datri registry. A total of 72,000 people have registered across the country. In Kerala, 11,000 have signed up, the highest so far, he said.

Among the common myths are that by donating stem cells one turns infertile and weak, have increased chances of cancer and also that there would be excess loss of blood, he said.

According to studies, over one lakh people are diagnosed with Leukemia (blood cancer) and other blood disorders every year in India.

The Indian Council of Medical Research has predicted that by the end of 2015, Leukemia cases will reach an estimated 1,17,649 and 1,32,574 by 2020. Stem cell therapy is a widely used treatment mechanism for Leukemia.

Here is the original post:
Stem cell therapy a boon for Parkinson patients

Read More...

Rowan Researcher Targets Stem Cell-Based Therapy for Rare Childhood Disease

Wednesday, February 25th, 2015

Contact Information

Available for logged-in reporters only

Newswise STRATFORD Paola Leone, PhD, the director of the Cell and Gene Therapy Center and a professor of Cell Biology at the Rowan University School of Osteopathic Medicine (RowanSOM), has been awarded a three-year, $477,000 grant from the National Institute of Neurological Disorders and Stroke (NINDS) to develop a stem cell-based therapy for Canavan disease, a rare but devastating neurological disorder in children that typically takes a childs life by age 10.

Canavan disease is a fatal, inherited disease caused by a mutation in the aspartaocylase gene, Dr. Leone explained. The disease is characterized by progressive and severe brain atrophy that manifests in delayed development, developmental regression, microcephaly, spasticity, seizures, visual impairment and short life expectancy. There, currently, is no treatment or cure for Canavan disease.

Under Dr. Leones direction, a team of RowanSOM researchers and students will examine the potential of stem cells for the treatment of Canavan disease in an animal model. This new study will build on the research teams preliminary data that demonstrated the successful engraftment of stem cells in animal models.

Our project will generate pre-clinical data to support the development of a stem-cell based therapy for Canavan disease, Dr. Leone said. It will also provide an important opportunity for a new generation of clinical researchers. Both undergraduate and graduate students will participate in this project, providing them with valuable experience to work with an extremely promising therapeutic intervention.

The symptoms of Canavan disease usually appear within the first six months of a childs life. The disease is caused by a genetic mutation that stops cells, called oligodendrocytes, from developing myelin, the fatty substance that coats the nerves in the brain. Without the protective myelin covering, the nerves do not form properly, causing the brain to atrophy. The preliminary research that Dr. Leone conducted showed that the engraftment of stem cells promoted significant recovery of the myelin sheath surrounding the nerves.

Our research represents a significant departure from other studies that have focused solely on strategies to augment the loss of the aspartaocylase function that is highly reduced in the brains of these patients, Dr. Leone said. We believe that any strategy seeking to treat Canavan must include a way to restore the myelin development that is disrupted in children with this disease.

This research is supported by the NINDS of the National Institutes of Health, under grant number 1R15NS088763-01A1.

Journalists wishing to speak with Dr. Leone, should contact Jerry Carey, Rowan University Media and Public Relations at 856-566-6171 or at careyge@rowan.edu.

Read more here:
Rowan Researcher Targets Stem Cell-Based Therapy for Rare Childhood Disease

Read More...

Stem Cell Research & Therapy | Full text | Aromatic …

Tuesday, February 24th, 2015

Abstract Introduction

Aromatic (ar-) turmerone is a major bioactive compound of the herb Curcuma longa. It has been suggested that ar-turmerone inhibits microglia activation, a property that may be useful in treating neurodegenerative disease. Furthermore, the effects of ar-turmerone on neural stem cells (NSCs) remain to be investigated.

We exposed primary fetal rat NSCs to various concentrations of ar-turmerone. Thereafter, cell proliferation and differentiation potential were assessed. In vivo, nave rats were treated with a single intracerebroventricular (i.c.v.) injection of ar-turmerone. Proliferative activity of endogenous NSCs was assessed in vivo, by using noninvasive positron emission tomography (PET) imaging and the tracer [18F]-fluoro-L-thymidine ([18F]FLT), as well as ex vivo.

In vitro, ar-turmerone increased dose-dependently the number of cultured NSCs, because of an increase in NSC proliferation (P<0.01). Proliferation data were supported by qPCR-data for Ki-67 mRNA. In vitro as well as in vivo, ar-turmerone promoted neuronal differentiation of NSCs. In vivo, after i.c.v. injection of ar-turmerone, proliferating NSCs were mobilized from the subventricular zone (SVZ) and the hippocampus of adult rats, as demonstrated by both [18F]FLT-PET and histology (P<0.05).

Both in vitro and in vivo data suggest that ar-turmerone induces NSC proliferation. Ar-turmerone thus constitutes a promising candidate to support regeneration in neurologic disease.

Curcumin and ar-turmerone are the major bioactive compounds of the herb Curcuma longa. Although many studies have demonstrated curcumin to possess antiinflammatory and neuroprotective properties (reviewed by [1]), to date, the effects of ar-turmerone remain to be elucidated. For example, antitumor properties, exerted via the induction of apoptosis [2] and inhibition of tumor cell invasion [3], have been attributed to ar-turmerone. Park et al. [4,5] recently suggested that ar-turmerone also possesses antiinflammatory properties resulting from the blockade of key signaling pathways in microglia. Because microglia activation is a hallmark of neuroinflammation and is associated with various neurologic disorders, including neurodegenerative diseases [6,7] and stroke [8,9], ar-turmerone constitutes a promising therapeutic agent for various neurologic disorders.

The regenerative potential of endogenous neural stem cells (NSCs) plays an important role in neurodegenerative disease and stroke. Endogenous NSCs are mobilized by cerebral ischemia [10] as well as by various neurodegenerative diseases [11,12], although their intrinsic regenerative response is insufficient to enable functional recovery. The targeted (that is, pharmacologic) activation of endogenous NSCs has been shown to enhance self-repair and recovery of function in the adult brain in both stroke [13,14] and neurodegeneration [15]. Importantly, NSCs and microglia relevantly interact with each other, thereby affecting their respective functions [16,17].

Thus, with the perspective of ar-turmerone as a therapeutic option in mind, we investigated the effects of ar-turmerone on NSCs in vitro and in vivo.

NSCs were cultured from fetal rat cortex at embryonic day 14.5, as described previously [18]. Cells were expanded as monolayer cultures in serum-free DMEM/F12 medium (Life Technologies, Darmstadt, Germany) with N2 supplement (Gibco, Karlsruhe, Germany) and fibroblast growth factor (FGF2; 10ng/ml; Invitrogen, Karlsruhe, Germany) for 5days and were replated in a 24-well plate at 10,000 cells per cm2. FGF2 was included throughout the experiments.

Ar-turmerone (Fluka, Munich, Germany) was added to cultures at replating at concentrations of 0, 1.56, 3.125, 6.25, 12.5, and 25g/ml. All experiments were performed in triplicate. After 72hours, representative pictures were taken by using an inverted fluorescence phase-contrast microscope (Keyence BZ-9000E). Three images were taken per well, and cells were counted by using the software ImageJ with a threshold of 20 px (National Institutes of Health, Bethesda, MD, USA, Version 1.47k).

See the article here:
Stem Cell Research & Therapy | Full text | Aromatic ...

Read More...

Stem Cell Therapy for Liver Failure Cirrhosis Kidney Damage – 6 Months After Stemcell Transplant – Video

Saturday, February 21st, 2015


Stem Cell Therapy for Liver Failure Cirrhosis Kidney Damage - 6 Months After Stemcell Transplant
Bruce from Perth Australia give us an update 6 Months After his cord Mesenchymal stem cell treatment for Iiver cirrhosis, kidney complications in Thailand: More here: http://stemcellthailand.org/th...

By: Regeneration Center of Thailand

Continue reading here:
Stem Cell Therapy for Liver Failure Cirrhosis Kidney Damage - 6 Months After Stemcell Transplant - Video

Read More...

Stem Cell Therapy Using Fat Cells – Howard Beach, Ozone Park, Queens NY – Dr. Benjamin Bieber, MD – Video

Friday, February 20th, 2015


Stem Cell Therapy Using Fat Cells - Howard Beach, Ozone Park, Queens NY - Dr. Benjamin Bieber, MD
Regenerative Medicine - Dr. Benjamin Bieber, MD - Howard Beach, Ozone Park, Queens NY http://www.crossbaypmr.com Phone: (718) 835-0100 Stem Cell Therapy Using Fat Cells Dr. Benjamin...

By: wpv wpvmedia

View post:
Stem Cell Therapy Using Fat Cells - Howard Beach, Ozone Park, Queens NY - Dr. Benjamin Bieber, MD - Video

Read More...

Ryan Benton Discusses Stem Cell Therapy for Duchenne’s Muscular Dystrophy – Video

Friday, February 20th, 2015


Ryan Benton Discusses Stem Cell Therapy for Duchenne #39;s Muscular Dystrophy
Ryan Benton is the first patient in the United States to receive human umbilical cord-derived mesenchymal stem cell therapy for Duchenne #39;s muscular dystrophy. The US FDA granted Ryan this...

By: http://www.cellmedicine.com

Read this article:
Ryan Benton Discusses Stem Cell Therapy for Duchenne's Muscular Dystrophy - Video

Read More...

Stem Cell Therapy Using Bone Marrow – Howard Beach, Ozone Park, Queens NY – Dr. Benjamin Bieber, MD – Video

Friday, February 20th, 2015


Stem Cell Therapy Using Bone Marrow - Howard Beach, Ozone Park, Queens NY - Dr. Benjamin Bieber, MD
http://www.crossbaypmr.com Stem Cell Therapy Using Bone Marrow - Howard Beach, Ozone Park, Queens NY - Dr. Benjamin Bieber, MD - Regenerative Medicine Phone:...

By: wpv wpvmedia

Go here to read the rest:
Stem Cell Therapy Using Bone Marrow - Howard Beach, Ozone Park, Queens NY - Dr. Benjamin Bieber, MD - Video

Read More...

Dr Ellis hosts seminar on Stem Cell Therapy & Facial Rejuvenation – Video

Wednesday, February 18th, 2015


Dr Ellis hosts seminar on Stem Cell Therapy Facial Rejuvenation
Dr. Dan Eglinton of Asheville Biologics and Orthopaedics, Dr. Sean Whalen and Dr. Paul Mogannam of Flexogenics and Dr. Laura Ellis of medAge speak about Stem Cell Therapy and skin ...

By: Dr. Laura Ellis

See original here:
Dr Ellis hosts seminar on Stem Cell Therapy & Facial Rejuvenation - Video

Read More...

Dr. Raj at Beverly Hills Orthopedic Institute Achieving 80% Success with Stem Cell Therapy

Tuesday, February 17th, 2015

Beverly Hills, CA (PRWEB) February 17, 2015

The top stem cell clinic in Los Angeles and Beverly Hills is now achieving 80% success with stem cell therapy for all types of arthritis and soft tissue indications. This includes hip, knee, shoulder, elbow and ankle injections for helping patients achieve pain relief and avoid surgery. Call (310) 438-5343 for more information on the treatment options available and scheduling.

Dr. Raj, who was recently named a Super Doc Southern California for the 4th year in a row, has been performing stem cell therapy on patients for years. This includes athletes, weekend warriors, celebrities, executives, senior citizens and students as well.

There are two methods offered for the treatment, one of which is Bone Marrow derived. This includes harvesting bone marrow from the patient's hip area, and then the material is immediately processed to concentrate the stem cells and growth factors. the fluid is then injected into the problem area. An internal review at Beverly Hills Orthopedic Institute has shown that 80% of patients achieve excellent pain relief and increased functional abilities. This includes getting back to athletics, recreational activities and walking more.

The second method of treatment involves amniotic derived stem cell rich injections. The amniotic fluid is processed at an FDA regulated lab, with no fetal tissue being involved and no embryonic stem cells at all. Amniotic fluid has been used tens of thousands of times worldwide for many indications, and contains growth factors, hyaluronic acid and stem cells.

Indications for the treatment include tennis and golfer's elbow, plantar fasciitis, degenerative arthritis of the hip, knee, shoulder, elbow, ankle, ligament injuries, and tendonitis of the shoulder, knee, achilles and more.

Dr. Raj is a Double Board Certified orthopedic doctor in Los Angeles and serves as an ABC News Medical Correspondent and a WebMD expert. He is called frequently by networks for his opinion on orthopedic matters, and is on the Medical Advisory Board for R3 Stem Cell.

For more information and scheduling with the top stem cell clinic in Los Angeles and Beverly Hills, call (310) 438-5343.

Read more here:
Dr. Raj at Beverly Hills Orthopedic Institute Achieving 80% Success with Stem Cell Therapy

Read More...

FAQ Part 1: MEsenchymal Stem cell therapy for CAnadian MS patients (MESCAMS) – Video

Saturday, February 14th, 2015


FAQ Part 1: MEsenchymal Stem cell therapy for CAnadian MS patients (MESCAMS)
The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation have announced a $4.2 million grant in support of the MEse...

By: MSSocietyCanada

Read the rest here:
FAQ Part 1: MEsenchymal Stem cell therapy for CAnadian MS patients (MESCAMS) - Video

Read More...

How about Stem Cell Therapy for LBD, Nova Cells Institute stem cells – Video

Saturday, February 14th, 2015


How about Stem Cell Therapy for LBD, Nova Cells Institute stem cells
Nova Cells Institute makes a difference because we care - like the Bumble Bee - doing the impossible- http://www.novacellsinstitute.com.

By: NCIM

Follow this link:
How about Stem Cell Therapy for LBD, Nova Cells Institute stem cells - Video

Read More...

Stem Cell Therapy for Erectile Dysfunction – Alvarado Hospital – Video

Saturday, February 14th, 2015


Stem Cell Therapy for Erectile Dysfunction - Alvarado Hospital
The first study in the U.S. to determine if stem cell therapy can treat erectile dysfunction. Alvarado Hospital #39;s Drs. Irwin Goldstein and Barry Handler discuss this FDA-approved study and...

By: AlvaradoHospital

More:
Stem Cell Therapy for Erectile Dysfunction - Alvarado Hospital - Video

Read More...

Cell Therapy Report 2014-2020 – Technologies, Markets and Companies

Tuesday, February 10th, 2015

DUBLIN, Feb .10, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/7zf9mz/cell_therapy) has announced the addition of Jain PharmaBiotech's new report "Cell Therapy - Technologies, Markets and Companies" to their offering.

This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is replacing the old fashioned bone marrow transplants. Role of cells in drug discovery is also described. Cell therapy is bound to become a part of medical practice.

Stem cells are discussed in detail in one chapter. Some light is thrown on the current controversy of embryonic sources of stem cells and comparison with adult sources. Other sources of stem cells such as the placenta, cord blood and fat removed by liposuction are also discussed. Stem cells can also be genetically modified prior to transplantation.

Cell therapy technologies overlap with those of gene therapy, cancer vaccines, drug delivery, tissue engineering and regenerative medicine. Pharmaceutical applications of stem cells including those in drug discovery are also described. Various types of cells used, methods of preparation and culture, encapsulation and genetic engineering of cells are discussed. Sources of cells, both human and animal (xenotransplantation) are discussed. Methods of delivery of cell therapy range from injections to surgical implantation using special devices.

Cell therapy has applications in a large number of disorders. The most important are diseases of the nervous system and cancer which are the topics for separate chapters. Other applications include cardiac disorders (myocardial infarction and heart failure), diabetes mellitus, diseases of bones and joints, genetic disorders, and wounds of the skin and soft tissues.

Regulatory and ethical issues involving cell therapy are important and are discussed. Current political debate on the use of stem cells from embryonic sources (hESCs) is also presented. Safety is an essential consideration of any new therapy and regulations for cell therapy are those for biological preparations.

The cell-based markets was analyzed for 2014, and projected to 2024.The markets are analyzed according to therapeutic categories, technologies and geographical areas. The largest expansion will be in diseases of the central nervous system, cancer and cardiovascular disorders. Skin and soft tissue repair as well as diabetes mellitus will be other major markets.

The number of companies involved in cell therapy has increased remarkably during the past few years. More than 500 companies have been identified to be involved in cell therapy and 294 of these are profiled in part II of the report along with tabulation of 285 alliances. Of these companies, 160 are involved in stem cells. Profiles of 72 academic institutions in the US involved in cell therapy are also included in part II along with their commercial collaborations. The text is supplemented with 61 Tables and 16 Figures. The bibliography contains 1,200 selected references, which are cited in the text.

Key Topics Covered:

Read more here:
Cell Therapy Report 2014-2020 - Technologies, Markets and Companies

Read More...

Cell Therapy may have just raised $1M, but will crowdfunding have a lasting place in biotech?

Tuesday, February 10th, 2015

Biotechs may be flush with cash, thanks to the ol bullish IPO market and an uptick in venture funding. But startups remainon the lookout for alternative funding models with crowdsourcing front and center.

This makes British biotech startup Cell Therapyparticularly interesting,itjustraised 689,246 or a bit over$1 million to launch a stem cell therapy for heart failure. This is one of the highest life sciences-related crowdfunding efforts topped only by Scanadu, whose handheld consumer diagnostic tool raised $1.6 million in Indiegogo.

Cell Therapy, which was founded by 2007 Nobel Prize winner Martin Evans, raised the funding on thesite Crowdcube exceeding its goal of 250,000 with backing from nearly 300 investors. It ceded a mere 0.39% in equity to the backers thatinclude investment bankers, hedge fund employees and scientists, CEO Ajan Reginald said.

It was very fast and very efficient, Reginaldtold Reuters. We have spent 5 percent of our time on fundraising, which enables me to spend 95 percent of my time on the business.

Crowdfunding is increasingly becoming an option for early stage biotechs that want to sidestep the traditional venture-backed approach. On one hand, its a relatively simple means to raise a large amount of seed capital but on the other, there are many more (potentially irate) investors to answer to when a companys in its nascence.

New York-based Poliwoggs entire premise is on bringing crowdfunding to healthcare with aims to help companies raise fundsfrom accredited investors beyond the seed stage, with rounds ranging from $2 million to $10 million mark.Notably, ithas its own regenerative medicine fund.

Part of the idea here is that people want to invest in the things they care about, but they havent always had the opportunity to invest in them, CEO Greg Simon told MedCity News.Were giving people the opportunity to put their money where their passion is.

Thats all fine and good to have a passion for a cause, but the traditional accredited investor whos enmeshed in a crowdfunding effort may still not understand the intricacies of what it takes to get results or a return in a tricky field like regenerative medicine.

John Carroll over atFierce Biotechopined that crowdfunding wont make a significant dent in the approach to life sciences crowdfunding. Stem cell therapy, after all, generated tons of media pomp and flair a decade ago, but has yet to deliver on many of its curative promises from back then. VCs are often burnt and reticent, and investors on crowdfunding sites will likely be, as well. Carroll says:

Read more here:
Cell Therapy may have just raised $1M, but will crowdfunding have a lasting place in biotech?

Read More...

FAQ Part 4: MEsenchymal Stem cell therapy for CAnadian MS patients (MESCAMS) – Video

Monday, February 9th, 2015


FAQ Part 4: MEsenchymal Stem cell therapy for CAnadian MS patients (MESCAMS)
The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation have announced a $4.2 million grant in support of the MEsenchymal Stem cell therapy for CAnadian.

By: MSSocietyCanada

View post:
FAQ Part 4: MEsenchymal Stem cell therapy for CAnadian MS patients (MESCAMS) - Video

Read More...

Neck and Shoulder arthritis two years after stem cell therapy by Harry Adelson, N.D. – Video

Friday, February 6th, 2015


Neck and Shoulder arthritis two years after stem cell therapy by Harry Adelson, N.D.
Steve describes his outcome two years after stem cell therapy for his arthritic neck and shoulder by Dr Harry Adelson http://www.docereclinics.com.

By: Harry Adelson, N.D.

Visit link:
Neck and Shoulder arthritis two years after stem cell therapy by Harry Adelson, N.D. - Video

Read More...

Okyanos Cell Therapy Success Brings Hope for a Normal Life

Thursday, February 5th, 2015

Freeport, Grand Bahama (PRWEB) February 04, 2015

In just a few short months since Okyanos opened its doors, remarkable results are becoming a daily reality. In light of these mounting successes, Okyanos, the leader in cell therapy, has augmented its adult stem cell therapy for severe heart disease and expanded their offerings to include treatments for patients with other chronic unmet needs. Now, patients like Patsy and Dylan are experiencing the tangible benefits that Okyanos cell therapy provides.

Patsy, 72 years old, lived a normal life until 2012 when a diagnosis of congestive heart failure (CHF) put a halt to her active lifestyle. Patsys health quickly deteriorated. Despite open heart surgery, a pacemaker and medications, all were insufficient to arrest her physical decline. Faced with a heart transplant as her next option and fearful of the idea, Patsy began searching for another alternative.

I was looking at going to Mexico, and my cardiologist was talking to me about being a part of a clinical trial where they inject two different kinds of drugs into the heart, but I was hesitant about that idea and worried I would get the placebo. A friend knew I had a heart problem, and she recommended Okyanos.

Patsys arrival at Okyanos quickly allayed any apprehension as she said, I couldnt ask to be treated any better than if they were my own sisters or brothers. It was truly amazing. You just dont get that kind of care in regular hospitals.

After just a few short months since her mid-October (2014) treatment with Okyanos cell therapy, Patsy is noticing improvements. Im doing better. I can already tell the difference. Im getting up the stairs more easily. Im doing the laundry again. I have more energy, and when you have more energy and you feel better, your point of view on life is betterit really makes a big difference.

Dylan is another success. At 16, Dylan had dreamt of a career playing tennis but began experiencing extreme pain with his hips locking up, causing him to fall to the ground. He was diagnosed with a rare condition that causes abnormal growth of tissue lining the joints that can later break off and damage cartilage. After 2 surgeries to clean out his hips, constant pain and an inability to walk without a limp, run or bend over, the condition worsened. After speaking with doctors, it was clear that continuation of regular surgeries would further deteriorate Dylans hips. Determined to see her son walk normally, Dylans mother discovered Okyanos and both decided to move forward with cell therapy.

Dylan underwent cell therapy wherein stem cells were separated from his own fat tissue for direct injections into the hip as well as delivery by IV to address underlying causes of ischemia, inflammation and abnormal immune response. Ten days later, Dylan was pain-free and able to walk normally, run and bend over.

Im pinching myself. Its amazing. No, its miraculous! says Elena about her sons recovery. If Dylan had not had the cell therapy, we would have kept doing other treatments and crossed our fingers. At 20 years old, his future would have been hip replacement surgery and a lifetime of problems walking, painful movement and an inability to bend down.

Stem cell therapy is a relatively simple and minimally-invasive same-day procedurea stark contrast from open heart surgery or hip surgeryyet offers patients the hope of a more normal life. Patients like Patsy concur, Its going to give people hope. And give them a life. You get to a point with a body where you push and push and run out of energy. Thats not really life to me. I think stem cell therapy can give back life.

View original post here:
Okyanos Cell Therapy Success Brings Hope for a Normal Life

Read More...

Florida Panther Receives Cutting Edge Stem Cell Procedure from MediVet Biologics

Thursday, February 5th, 2015

Nicholasville, KY (PRWEB) February 04, 2015

Rescued when he was only 4 weeks old, Nakiia, a 15-year-old Panther, has been living in severe pain after a jumping incident. Jan Hall, Nakiias owner has dedicated her life to rescuing animals. Nakiia, the namesake of her rescue foundation The Nakiia Foundation is the love of her life. Witnessing this fabulous animal in such pain was too much for Jan to bear. The Doctors treating Nakiia decided to undertake a revolutionary medical procedure, which centers on regenerative medicine.

Newman Veterinary Center in DeLand Florida performed MediVets Adipose (fat)-derived stem cell therapy. The male Florida panther underwent this procedure, more commonly performed on domestic animal such as dogs, cats and horses. The procedure is an effort to ease the pain from severe arthritis in his joints. This was a last stage effort for the panther that can no longer continue to live in such pain.

Though stem cell treatments have been performed in exotic animals before, it is still a rare and exciting undertaking. Utilizing MediVet Biologics procedure, Dr. Ted Oliver was able to ensure the process will produce the best possible results. MediVets procedure is completed in one day and in-clinic.

Stem Cell treatments in the past have often been controversial when embryonic cells where involved, with adipose or fat tissue Nakiias own adult stem cells could be easily concentrated and activated with minimal risk. Until recently Veterinarians only had the option of utilizing outside labs for processing of autologous cells, with the one step surgical treatment available from MediVet Biologics, Veterinarians all around the country can eliminate the costs and variability in shipping by utilizing an onsite simple procedure.

During the procedure, Dr. Oliver removed about four tablespoons of belly fat from the panther. The fat was then processed in-clinic by a trained technician. The cells are incubated, isolated and activated by a patented process. Dr. Oliver carefully re-administered the cells directly back into Nakiia. Nakiias excess cells will be stored for future use eliminating the need to surgically re-harvest additional tissue.

MediVets primary mission and goal is to help all animals live a pain free life. In regenerative medicine and biologic intervention age is not a disease rather a challenge that presents us many opportunities to develop cutting edge treatments to combat issues related to the aging process. Our partnerships with progressive Veterinarians such as Newman Veterinary Centers allow us to extend affordable cutting edge treatments to animals who otherwise potentially have limited treatments available. We look forward to following Nakiias progress." - Jeremy Delk, CEO of MediVet Biologics.

Newman Veterinary Center was honored to be a part of Nakiias stem cell procedure. The excitement that this 146-lb. cat brought to our clinic was unparalleled. We have very high hopes that Nakiia will be feeling much better very soon. - Erica Kent Director of Operations at Newman Veterinary Centers.

Nakiias story will air on Wednesday, February 4th on CBS WKMG (local 6) with Mike Holfeld, Investigative Reporter.

About MediVet Biologics MediVet Biologics is the Worlds leading provider of Veterinary regenerative medicine. The central Kentucky based company was founded in 2009 and quickly gained favor in the Veterinary industry with the advent of in-clinic adipose derived stem cell and platelet rich plasma treatments. Since gaining wide appeal in the small and large veterinary market MediVet Biologics has developed a strong biologic pipeline that includes, among other cutting edge treatment options, patient specific immunotherapy services.

More here:
Florida Panther Receives Cutting Edge Stem Cell Procedure from MediVet Biologics

Read More...

Page 4«..3456..1020..»


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick